CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Telaprevir

Last Updated: February 19, 2013
Result type: Reports
Project Number: SF0311
Product Line: Common Drug Review

Generic Name: Telaprevir

Brand Name: Incivek

Manufacturer: Vertex Pharmaceuticals Canada Inc.

Indications: Hepatitis C infection, chronic

Submission Type: Request For Advice

Project Status: Complete

Date Recommendation Issued: June 13, 2013

Recommendation Type: List with criteria/condition